Evidence map›Paper›PMID 30305089›Full record

ArticleJournal of translational medicine2018

Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar).

Sara Deola, Bella S Guerrouahen, Heba Sidahmed, Anjud Al-Mohannadi, Muhammad Elnaggar, Ramaz Elsadig, Essam M Abdelalim, Goran Petrovski, Massimo Gadina, Adrian Thrasher and 7 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sara DeolaResearch Department, Clinical Research Center, Sidra Medicine, Doha, Qatar.
Bella S GuerrouahenResearch Department, Clinical Research Center, Sidra Medicine, Doha, Qatar.
Heba SidahmedResearch Department, Clinical Research Center, Sidra Medicine, Doha, Qatar.
Anjud Al-MohannadiResearch Department, Clinical Research Center, Sidra Medicine, Doha, Qatar.
Muhammad ElnaggarResearch Department, Clinical Research Center, Sidra Medicine, Doha, Qatar.
Ramaz ElsadigResearch Department, Clinical Research Center, Sidra Medicine, Doha, Qatar.
Essam M AbdelalimDiabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Education City, Doha, Qatar.
Goran PetrovskiEndocrinology Unit, Sidra Medicine, Doha, Qatar.
Massimo GadinaNational Institutes of Health, Bethesda, MD, USA.
Adrian ThrasherUCL Great Ormond Street Institute of Child Health, London, UK.
Winfried S WelsGeorg Speyer Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.
Stephen P HungerChildren's Hospital of Philadelphia, Philadelphia, USA.
Ena WangImmune Oncology Discovery and System Biology, AbbVie, Redwood City, CA, USA.
Francesco M MarincolaRefuge Biotechnologies Inc., Menlo Park, CA, USA.
ATH Consortium
Cristina MaccalliResearch Department, Clinical Research Center, Sidra Medicine, Doha, Qatar.
Chiara CugnoResearch Department, Clinical Research Center, Sidra Medicine, Doha, Qatar. ccugno@sidra.org.ORCID 0000-0002-1664-3030

Funding

Translational Immunology research: a support for clinical immunological researchZICAR041181 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI GADINA, MASSIMO · 2009 to 2025
$31.5M
Qatar National Research Fund NPRP10-1221-160041Qatar National Research Fund NPRP9-283-3-056QBRI/HBKU IGP 2014-009QBRI/HBKU IGP 2016-001
6 · The paper itself

Abstract

New technologies and therapies designed to facilitate development of personalized treatments are rapidly emerging in the field of biomedicine. Strikingly, the goal of personalized medicine refined the concept of therapy by developing cell-based therapies, the so-called "living drugs". Breakthrough advancements were achieved in this regard in the fields of gene therapy, cell therapy, tissue-engineered products and advanced therapeutic techniques. The Advanced Therapies in Healthcare symposium, organized by the Clinical Research Center Department of Sidra Medicine, in Doha, Qatar (October 2017), brought together world-renowned experts from the fields of oncology, hematology, immunology, inflammation, autoimmune disorders, and stem cells to offer a comprehensive picture of the status of worldwide advanced therapies in both pre-clinical and clinical development, providing insights to the research phase, clinical data and regulatory aspects of these therapies. Highlights of the meeting are provided in this meeting report.

Indexed as

Cell- and Tissue-Based TherapyPrecision MedicineGenetic TherapyHumansImmunotherapyMolecular Targeted TherapyNeoplasmsQatarAutoimmunityCell therapyClinical trialsGene therapyHematologyOncologyPersonalized medicinePreclinicalStem cells

Identifiers

PMID30305089
PMCPMC6180452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.